The Israel Cancer Research Fund (ICRF), the only voluntary charitable organization in North America solely devoted to supporting cancer research in Israel, is excited to announce a remarkable funding milestone of $100,000,000. Established in 1975, ICRF has consistently demonstrated a steadfast commitment to advancing scientific breakthroughs by providing critical grants to pioneering cancer researchers across Israel鈥檚 leading institutions, universities, and hospitals. This monumental funding achievement represents not only a financial benchmark but also a resounding endorsement of ICRF鈥檚 mission to support cancer research in Israel for the benefit of both local communities and patients worldwide. With this incredible infusion of resources, the organization is well-positioned to drive forward innovative research projects, accelerate the development of new therapies and treatment modalities, and ultimately, extend hope and healing far beyond Israel's borders. The funds will empower cutting-edge laboratories and research centers, amplify collaborative efforts among renowned scientists, and enhance infrastructure investments that make groundbreaking discoveries possible. Moreover, it reinforces the organization鈥檚 dedication to transparent, high-impact philanthropy, ensuring that every dollar is strategically deployed to generate tangible medical advancements. As the Israel Cancer Research Fund continues its journey of relentless exploration in the fight against cancer, this funding milestone serves as a catalyst for future innovations and a testament to the enduring support of donors, partners, and the global community. Ultimately, the achievement underscores the shared urgency of addressing cancer through research, fostering a future where every innovative step brings us closer to a world free from the burden of this devastating disease.
Breaking New Ground: Israel Cancer Research Fund Secures $100 Million to Propel Israeli Cancer Research Forward
Recently funded 路 $100.0MNon-profit Organization Management
Get the full Israel Cancer Research Fund company profile
Access contacts, investors, buying signals & more
Other recently funded companies
View all
Laihua Online
Wuhan Laihua Information and Technology is an Internet leading source of information on educational opportunities for students to study in other countries especially in China. Either prospect is planning to come to China or is already in China for education (self-support or scholarship based) he will probably need one of the ranges of services we provide from Education, Translation, Notarization of legal documents to Internships & Jobs or Medical Tourism etc. It is a comprehensive directory of study abroad programs, including summer study abroad, service learning, intensive language programs and more. Wuhan Laihua Information and Technology first set out to fill the information gap between students with a desire to travel abroad to study and companies offering international programs.
$68.0M Series d
today
NEW ID
NEW ID is the latest subsidiary company of NEW, which has started up since August 2019 for a new digital contents/platform business domain. We are responsible for expanding the contents produced and acquired by NEW into various markets and creating our digital capabilities through partnering with a-lister digital content creators and providers in Korea.
